Adele Deering

Adele Deering has extensive work experience in the pharmaceutical industry. Adele is currently the Head of Commercial Operations for EMEA at Insmed Incorporated, where they oversee access, commercial excellence, marketing, and alliance management. Adele is also responsible for product launches, identifying new territories, and managing partner markets. Prior to this role, they worked as a Senior Director and Global Commercial Lead for Endocrinology at both Takeda and Shire. At Shire, they also served as a Global Brand Lead for Endocrinology, a Director of Strategy and Operations, and a Director of Commercial Collaboration Management and Market Expansion. Adele also has experience in corporate development as an Associate Director at Elan and in research as a Director at Vasogen Ireland Limited and a Research Assistant at the Royal College of Surgeons in Ireland.

Adele Deering completed their education from 1996 to 1999 at Technological University Dublin, although specific details about their degree and field of study are not provided in the information. Following that, they pursued an MSc in Pharmacology from The Royal College of Surgeons in Ireland from 1998 to 2000. Adele then went on to earn an MBA in Business Administration and Management, General from Henley Business School, where they studied from 2004 to 2008. Adele also holds an additional certification in MBA from Henley Business School, although the obtained month and year are not specified.